Skip to main content
CASTLE BIOSCIENCES INC logo

CASTLE BIOSCIENCES INC — Investor Relations & Filings

Ticker · CSTL ISIN · US14843C1053 LEI · 2549007M2Q4HLR1XD252 US Human health and social work activities
Filings indexed 792 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country US United States of America
Listing US CSTL

About CASTLE BIOSCIENCES INC

https://castlebiosciences.com/

Castle Biosciences Inc. is a diagnostics company that develops and commercializes innovative tests to guide patient care and improve health outcomes. The company focuses on translating a patient's unique tumor biology, particularly through gene expression profiling, into clinically actionable prognostic and diagnostic information. Its primary portfolio includes tests for dermatologic cancers, such as cutaneous melanoma and squamous cell carcinoma. These molecular tests are designed to provide healthcare providers with critical data to inform personalized disease management and treatment strategies. The clinical validity and utility of Castle Biosciences' tests are supported by an extensive body of peer-reviewed publications.

Recent filings

Filing Released Lang Actions
8-K - CASTLE BIOSCIENCES INC (0001447362) (Filer)
Regulatory Filings
2026-05-06 English
ARS - CASTLE BIOSCIENCES INC (0001447362) (Filer)
Annual Report
2026-04-08 English
DEF 14A - CASTLE BIOSCIENCES INC (0001447362) (Filer)
Proxy Solicitation & Information Statement
2026-04-08 English
144 - CASTLE BIOSCIENCES INC (0001447362) (Subject)
Regulatory Filings
2026-03-26 English
10-K - CASTLE BIOSCIENCES INC (0001447362) (Filer)
Annual Report FY 2025
2026-02-26 English
8-K - CASTLE BIOSCIENCES INC (0001447362) (Filer)
Regulatory Filings
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.